Mr. Stern has extensive experience with the licensing of domestic and foreign patents and other proprietary rights by and to technology companies, as well as the exploitation of their technology through joint ventures, corporate partnering, research and development and distribution agreements. He has also been involved in a number of creative financing arrangements for technology clients.
Prior to joining Goodwin, Mr. Stern was a shareholder in the Silicon Valley office of Heller Ehrman, where he was a past chair and served on its executive committee for more than 20 years.
Mr. Stern was the incorporator of ALZA Corporation and has served as its secretary and a director since its founding until its merger with Johnson and Johnson. He was the incorporator of Affymax and served as its secretary and a managing director from inception until its acquisition by Glaxo. Mr. Stern was also the incorporator of Cetus Corporation and served as its secretary since incorporation and as a director until its acquisition by Chiron and has been an advisory director of Chiron. He is the incorporator of A.P. Pharma, Inc. and Maxygen, Inc. and has served as their secretary since their incorporation, as well as being secretary and director of a number of privately held technology companies.